The Speciality Medicines IPO subscription status shows how many times the issue has been subscribed across different investor categories such as QIB, NII (HNI), and Retail. It reflects the demand for the IPO during the subscription period.

You can check live Speciality Medicines IPO subscription data on this page, which is updated based on official exchange data released during the IPO subscription period.

The Speciality Medicines IPO subscription is divided into the following categories: Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII / HNI), and Retail Individual Investors (RII). Each category has a separate quota and subscription data.

QIB subscription in Speciality Medicines IPO indicates the demand from institutional investors such as mutual funds, banks, and insurance companies.

NII (also known as HNI) subscription in Speciality Medicines IPO represents bids from high-net-worth investors who apply for shares above the retail limit.

Retail subscription in Speciality Medicines IPO shows demand from individual investors who apply within the retail investment limit specified in the IPO details.

Speciality Medicines IPO subscription data is updated multiple times during market hours based on information published by stock exchanges.

No, higher Speciality Medicines IPO subscription does not guarantee allotment. In case of oversubscription, allotment is done through a lottery system as per SEBI guidelines.

Yes, the subscription data shown for Speciality Medicines IPO is based on official data released by stock exchanges, but it may change during the day.

IPO subscription indicates demand, but the actual listing performance depends on market conditions, company fundamentals, and investor sentiment at the time of listing.